Рет қаралды 3,347
Novartis’s next generation Technology Platforms strategy was outlined to investors by our CEO, Vas Narasimhan.
Our new strategy provides a focus on five technology platforms - highlighting an increasing shift towards biologics and advanced technology platforms. We will shift towards both biologics and advanced technology platforms and build leadership across three next-generation technology platforms: xRNA, Radioligand, and Gene and Cell Therapy.
0:00
0:14 Advanced technology platforms
0:33 Gene therapy
0:53 Cell therapy
1:25 Radioligand therapy
JP Morgan Healthcare Conference
Event Date: January 9, 2023
Investors Events: bit.ly/409A4p4
Novartis Strategy: bit.ly/3R0frqY
Disclaimer: JP Morgan healthcare conference contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: bit.ly/3WGTkHC
Follow @Novartis on Twitter: / novartis
Follow Novartis on LinkedIn: / novartis